{"slideshow_credits": null, "snippet": "The index ranks pharmaceutical companies based on how readily they get medicines to the world\u2019s poor, how much research they do on tropical diseases and how ethically they conduct clinical trials.", "abstract": "GlaxoSmithKline holds on to top spot in Access to Medicines Index, which ranks world's top 20 pharmaceutical companies in terms of how readily they get medicines to world's poor; index does, however, show other competitors closing in.", "section_name": "Health", "print_page": "6", "document_type": "article", "byline": {"person": [{"lastname": "McNEIL", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "role": "reported", "organization": "", "middlename": "G."}], "original": "By DONALD G. McNEIL Jr", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/12/04/health/glaxosmithkline-tops-access-to-medicines-index.html", "lead_paragraph": "The index ranks pharmaceutical companies based on how readily they get medicines to the world\u2019s poor, how much research they do on tropical diseases and how ethically they conduct clinical trials.", "headline": {"seo": "GlaxoSmithKline Tops Access to Medicines Index", "main": "Pharmaceuticals: GlaxoSmithKline Retains Top Ranking Measuring Outreach to Poor Countries", "print_headline": "Pharmaceuticals: GlaxoSmithKline Retains Top Ranking Measuring Outreach to Poor Countries", "content_kicker": "Global Update", "kicker": "Global Update"}, "_id": "50be626200315214fbb7d65f", "word_count": "240", "multimedia": [{"height": 310, "url": "images/2012/12/04/science/04GLOB_SPAN/04GLOB-articleLarge.jpg", "legacy": {"xlarge": "images/2012/12/04/science/04GLOB_SPAN/04GLOB-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "310"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/12/04/science/04GLOB_SPAN/04GLOB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/12/04/science/04GLOB_SPAN/04GLOB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-12-04T00:00:00Z", "source": "The New York Times", "news_desk": "Science", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Third World and Developing Countries", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}